// App-Quantinova.ai

BSH19‐OR‐015 : Clinical Utility of The Serum Free Light Chain Assay in Primary Care

Researchers

Presenter

  • C. Lodwick

Principal Investigators

  • G. Pratt

  • M. Drayson

  • W. Lester

Medical Centers

  • Haematology, University Hospital Birmingmham

  • Haematology, University Hospital Birmingmham

  • Institute of Immunology and Immunotherapy,

  • University of Birmingham, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Peripheral Nervous System

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Monoclonal gammopathy

  • Mantle cell lymphoma

  • Renal insufficiency

  • Hypercalcaemia

  • Peripheral neuropathy

  • Lymphomas

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • Lanthanum carbonate

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A